Head to Head Comparison: Nano-X Imaging (NASDAQ:NNOX) & Avita Medical (NASDAQ:RCEL)

Nano-X Imaging (NASDAQ:NNOX) and Avita Medical (NASDAQ:RCEL) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, risk, valuation and profitability.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Nano-X Imaging and Avita Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	1	2	2	1	2.50
Avita Medical	1	1	5	0	2.57

Nano-X Imaging currently has a consensus price target of $4.33, suggesting a potential upside of 959.49%. Avita Medical has a consensus price target of $12.20, suggesting a potential downside of 6.41%. Given Nano-X Imaging’s higher probable upside, equities research analysts plainly believe Nano-X Imaging is more favorable than Avita Medical.

Valuation & Earnings

This table compares Nano-X Imaging and Avita Medical”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$13.02 million	2.47	-$75.02 million	($2.14)	-0.19
Avita Medical	$71.61 million	5.60	-$48.59 million	($1.44)	-9.05

Avita Medical has higher revenue and earnings than Nano-X Imaging. Avita Medical is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 27.7% of Avita Medical shares are owned by institutional investors. 2.2% of Avita Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Nano-X Imaging and Avita Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-926.05%	-116.93%	-100.67%
Avita Medical	-56.96%	N/A	-78.53%

Volatility & Risk

Nano-X Imaging has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500. Comparatively, Avita Medical has a beta of 1.99, indicating that its share price is 99% more volatile than the S&P 500.

Summary

Avita Medical beats Nano-X Imaging on 12 of the 15 factors compared between the two stocks.

About Nano-X Imaging

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

About Avita Medical

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.